Cartilage Oligomeric Matrix Protein as A Serological Biomarker for the Assessment of Liver Fibrosis Before and After Treatment of HCV Infection | Mohamed Eldesouky

Cartilage Oligomeric Matrix Protein as A Serological Biomarker for the Assessment of Liver Fibrosis Before and After Treatment of HCV Infection

Citation:: Ragab, A. A., S. O. Abdallah, G. E. Shiha, H. Ismail, M. S. Albannan, and M. A. El-Desouky, "Cartilage Oligomeric Matrix Protein as A Serological Biomarker for the Assessment of Liver Fibrosis Before and After Treatment of HCV Infection", Egyptian Journal of Chemistry, vol. 65, issue 9, pp. 93-98, 2022.